Nelson Peltz’s Trian Fund Bets on Mondelez and PepsiCo Among Others

Trian Fund Management LLC, led by Nelson Peltz, focuses on insurance companies, pension funds and university endowments. In a 13F filing, the fund revealed its holding for the fourth quarter. The value of its equity portfolio has marginally increased to $5.93 million from $5.46 million in the third quarter. We have selected five largest holdings – in terms of value – that Trian Fund has held in his equity portfolio, at the end of last year.


Out of the top-five largest value holdings, the first on the list is Mondelez International, Inc., (NASDAQ:MDLZ), a $59.84 billion market cap, snack manufacturing company. The position in the company increased to 41.47 million shares, from 40.95 million shares held in the third quarter of last year. The value of the holding went up to $1.46 billion, compared to $1.29 billion.

Second of the top-five companies in Trian Fund Management’s equity portfolio is PepsiCo, Inc. (NYSE:PEP), the global food and beverage company. The fund has increased the position marginally to 12.35 million shares in the fourth quarter, with an aggregate value of $1.02 billion.

Third on the top-five list is Wendy’s Co (NASDAQ:WEN) with 83.00 million shares, valued at $723.76 million. The position remained flat 0ver the quarter; however, the value of the holding increased from $703.84 million. Wendy’s Co (NASADQ:WEN) is a quick-service restaurant company focused on the hamburger sandwich segment.

Trian Fund’s fourth-largest holding is Ingersoll-Rand Plc (NYSE:IR) with $672.39 million stake. The fund holds 10.92 million shares, sliced from 12.90 million shares held at the end of the third quarter of last year. The company is a diversified global company and provides solutions to enhance air in homes.

And the last but not the least is Legg Mason Inc. (NYSE:LM). The stake has remained unchanged, amassing 12.87 million shares. The value of  holding in the asset management company Legg Mason, however, increased to $560.31 million in the last quarter compared to $430.92 million in the third quarter of 2013.

Disclosure: none

Recommended Reading:

Billionaire Stan Druckenmiller’s Top Stock Picks

Mark Rachesky and MHR Fund Management’s New Stock Moves

John Horseman’s Top Picks From the Latest 13F

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!